Other substances

Sitagliptin

An antidiabetic.

Phase of research

Potential treatment - clinical evidence

How it helps

Other treatment

Drug status

Used to treat other disease

0
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

Sitagliptin is an antidiabetic compound as an adjunct to diet and exercise to improve blood sugar control in adults diagnosed with type 2 diabetes mellitus (T2DM). Clinical findings have shown that the combined treatment of metformin and sitagliptin is more effective compared to the use of metformin alone in the treatment of patients who have both T2DM and COVID-19 (Kuraishy et al., 2021).

Sitagliptin on PubChem
Sitagliptin on DrugBank
Sitagliptin on Wikipedia

Marketed as

Janumet; Januvia; Ristaben; Steglujan; Tesavel; Velmetia; Xelevia

 

Structure image - Sitagliptin

C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)C[C@@H](CC3=CC(=C(C=C3F)F)F)N 

Export (.csv)